英国确诊注意缺陷多动障碍成人的预期寿命与寿命损失年:匹配队列研究
该匹配队列研究利用2000—2019年英国792家全科诊所的初级保健数据,纳入30039名18岁以上确诊注意缺陷多动障碍(ADHD)成人及1:10匹配对照300390人,采用泊松回归与寿命表法估算预期寿命。结果显示确诊ADHD成人相对一般人群的预期寿命缩短男性6.78年(95%CI 4.50–9.11)、女性8.64年(95%CI 6.55–10.91)。作者认为可能归因于可改变的危险因素及ADHD与共病精神躯体疾病的支持治疗需求未满足。
要点
- 确诊ADHD成人预期寿命较一般人群缩短:男性6.78年(95%CI 4.50–9.11),女性8.64年(95%CI 6.55–10.91)。
- 队列中约0.32%成人有ADHD诊断,约占所有ADHD成人的1/9。
- 确诊ADHD成人常见躯体与精神疾病诊断多于对照。
核心结论
- 确诊ADHD成人寿命短于应有水平。
- 作者认为这可能由可改变的危险因素及ADHD与共病精神躯体疾病的支持治疗需求未满足所致。
- 研究结果可能不适用于全部ADHD成人,其中绝大多数未确诊。
研究设计与样本
- 匹配队列研究,使用2000—2019年前瞻性收集的英国初级保健数据,覆盖792家全科诊所、9 561 450人贡献合格人时。
- 识别30 039名18岁以上确诊ADHD者,并按年龄、性别和全科诊所1:10匹配300 390名对照。
- 采用泊松回归估计年龄别死亡率,并用寿命表法估算18岁以上确诊ADHD者的预期寿命。
主要发现
- 队列中约0.32%成人有ADHD诊断,约占所有ADHD成人的1/9。
- 确诊ADHD成人常见躯体与精神疾病诊断较对照更常见。
- 确诊ADHD成人相对一般人群的预期寿命缩短:男性6.78年(95%CI 4.50–9.11),女性8.64年(95%CI 6.55–10.91)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究纳入的是确诊ADHD成人数据,结果可能不适用于全部ADHD成人,其中绝大多数未确诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nearly 3% of adults have attention-deficit and hyperactivity disorder (ADHD), although in the UK, most are undiagnosed. Adults with ADHD on average experience poorer educational and employment outcomes, worse physical and mental health and are more likely to die prematurely. No studies have yet used mortality data to examine the life expectancy deficit experienced by adults with diagnosed ADHD in the UK or worldwide. AIMS: This study used the life-table method to calculate the life-expectancy deficit for people with diagnosed ADHD using data from UK primary care. METHOD: A matched cohort study using prospectively collected primary care data (792 general practices, 9 561 450 people contributing eligible person-time from 2000-2019). We identified 30 039 people aged 18+ with diagnosed ADHD, plus a comparison group of 300 390 participants matched (1:10) by age, sex and primary care practice. We used Poisson regression to estimate age-specific mortality rates, and life tables to estimate life expectancy for people aged 18+ with diagnosed ADHD. RESULTS: Around 0.32% of adults in the cohort had an ADHD diagnosis, ~1 in 9 of all adults with ADHD. Diagnoses of common physical and mental health conditions were more common in adults with diagnosed ADHD than the comparison group. The apparent reduction in life expectancy for adults with diagnosed ADHD relative to the general population was 6.78 years (95% CI: 4.50 to 9.11) for males, and 8.64 years (95% CI: 6.55 to 10.91) for females. CONCLUSIONS: Adults with diagnosed ADHD are living shorter lives than they should. We believe that this is likely caused by modifiable risk factors and unmet support and treatment needs in terms of both ADHD and co-occurring mental and physical health conditions. This study included data from adults with diagnosed ADHD; the results may not generalise to the entire population of adults with ADHD, the vast majority of whom are undiagnosed.
引用
- O'Nions E, El Baou C, John A, et al. Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study. Br J Psychiatry. 2025. PMID: 39844532. doi:10.1192/bjp.2024.199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。